Rituxan Sales Of $37.7 Mil. Offset Declines In Other Genentech Products

Sales of Genentech/Idec's Rituxan have reached $43.2 mil. since launch, with sales of $5.5 mil. in the fourth quarter of 1997 and $37.7 mil. in the first quarter of 1998. FDA approved Rituxan Nov. 26.